Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG: The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994, 12(6):542-550.CDC. The Vaccine Adverse Event Reporting system[J].Morbidity and Mortality Weekly Report 1997,46.Varricchio F. The vaccine ...
Reporting adverse vaccine events.Discusses the effort of U.S. group Adverse Event Working Group to develop a system through which veterinarians can report adverse vaccine events. Absence of practical safety information on vaccine labels; Reasons for the failure of a previous system that monitors ...
内容提示: Vaccine 30 (2012) 7253–7259Contents lists available at SciVerse ScienceDirectVaccinejournal homepage: www.elsevier.com/locate/vaccineCausality assessment of adverse events reported to the Vaccine Adverse EventReporting System (VAERS)Anita M. Loughlina,b,∗, Colin D. Marchanta, William ...
17 To identify if other vaccines were coadministered along with the HPV vaccine, if a patient had an existing medical condition at the time the vaccine was administered, and whether the reported event was based on a social media post (as opposed to a direct report from a patient or a ...
(NVICP aka The Vaccine Court), the Advisory Commission on Childhood Vaccines (ACCV) and National Vaccine Advisory Committee (NVAC) federal committees, the Vaccine Adverse Event Reporting System (VAERS) system, it also charged the IOM with reviewing existing literature regarding adverse events ...
The US Vaccine Adverse Event Reporting System (VAERS) is a passive reporting system to which anyone can report an event. Publicity related to potential adverse events may change reporting patterns. The objective of this paper is to show how litigation-related reports have influenced the trends in...
A final report from the EMA based on many combined studies, including those performed by GSK, focused on the possible role of the antigen as the possible cause of increased narcolepsy and made no direct link with the adjuvant [72]. Hence, the problem can likely be avoided in the future ...
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS): United States, 1991-2001. MMWR Surveill Summ. 2003;52(1):1-2412825543PubMedGoogle Scholar 34. Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety: a system to detect early ...
adverse events, such as VAERS. Similar to VAERS, reporting by patients, clinicians, or health systems is needed to identify and report potential adverse events. An advantage of enhanced passive surveillance, however, is the potential availability of denominator data (ie, number of doses ...
Compared to males, females were more likely to report vaccine-related AEs and to be nocebo prone.[4] Concerning age, similar rates of systemic adverse events were reported in children 5-11 years old and in subjects 16-55 years old receiving placebo in the RCTs evaluating the effectiveness ...